机译:肺癌个性化治疗的国家肺基质试验
Univ Birmingham Inst Immunol & Immunotherapy Birmingham W Midlands England|Univ Hosp Birmingham NHS Fdn Trust Birmingham W Midlands England;
Univ Birmingham Canc Res UK Clin Trials Unit Birmingham W Midlands England;
Royal Marsden Hosp London England;
Univ Birmingham Canc Res UK Clin Trials Unit Birmingham W Midlands England;
The Christie Manchester Lancs England;
Newcastle Univ Newcastle Upon Tyne Tyne & Wear England;
Addenbrookes Hosp Cambridge England;
Southampton Univ Hosp NHS Trust Southampton Hants England;
Beatson West Scotland Canc Ctr Glasgow Lanark Scotland;
Velindre Canc Ctr Cardiff Wales;
Royal Devon & Exeter Fdn NHS Trust Exeter Devon England;
Kings Coll London Guys Hosp London England;
St James Univ Hosp Leeds W Yorkshire England;
Bristol Haematol & Oncol Ctr Bristol Avon England;
Western Gen Hosp Edinburgh Midlothian Scotland;
Univ Coll Hosp London England;
Univ Birmingham Inst Appl Hlth Res Birmingham W Midlands England;
Univ Birmingham Canc Res UK Clin Trials Unit Birmingham W Midlands England;
Univ Birmingham Canc Res UK Clin Trials Unit Birmingham W Midlands England;
Univ Birmingham Canc Res UK Clin Trials Unit Birmingham W Midlands England;
Canc Res UK London England;
Canc Res UK London England;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Francis Crick Inst London England;
Francis Crick Inst London England;
Francis Crick Inst London England|UCL Inst Canc Canc Res UK Lung Canc Ctr Excellence London England;
Univ Birmingham Canc Res UK Clin Trials Unit Birmingham W Midlands England;
机译:使用国家肺部筛选试验数据集的个性化肺癌风险预测和成像后续建议
机译:全国肺基质试验:针对非小细胞肺癌的多药,遗传标记指导,非比较,多中心,多组II期临床试验
机译:国家肺癌筛查试验美国放射学院影像网络标本生物资源库起源于当代肺癌筛查试验筛查(NLST,ACRIN 6654):标本的设计,意图和可用性,以验证肺癌生物标志物。
机译:3D保形放射治疗和定性体放射治疗对肺癌患者放射致肺灌注分布的变化
机译:α一抗胰蛋白酶,中性粒细胞弹性蛋白酶和基质金属蛋白酶一的遗传决定因素与COPD,肺癌和肺癌生存风险的关联。
机译:使用国家肺部筛选试验数据集的个性化肺癌风险预测和成像后续建议
机译:PL02.09国家肺基质试验(NLMT):先进的非小细胞肺癌(NSCLC)中的伞形二期试验中的首先结果
机译:肺癌治疗的无创个性化使用基于血浆的测量和监测肿瘤基因型的新的临床级分析。